Bhaskar Shetty murder: Rajeshwari withdraws bail plea from apex court

coastaldigest.com news network
August 11, 2017

Udupi, Aug 11: Rajeshwari Shetty, prime accused in the murder of her husband and NRI husband Bhaskar Shetty, on Thursday withdrew her plea seeking bail after the Supreme Court indicated to her counsel that it cannot consider her appeal at present as the police wanted to carry out additional investigation in the case.

When Rajeshwari's petition seeking release on bail came up for hearing before a Bench of Justice S A Bobde and Justice L. Nageswara Rao, counsel for the State said that additional investigation will be carried out in the case.

When the Bench indicated that it cannot consider the plea for bail at this stage, her counsel sought court’s permission to withdraw the petition with the liberty to renew the prayer for bail after six months or after additional investigation is over, whichever is earlier.

Following this submission, the court treated the petition as “dismissed as withdrawn” while granting liberty to her to approach the court again as sought for.

Bhaskar Shetty, who owned big businesses in Saudi Arabia and Udupi, went missing from his house here on July 28, 2016. The charge sheet has alleged that Rajeshwari Shetty had killed her husband.

Comments

Ganesh
 - 
Friday, 11 Aug 2017

SC should not give bail to this woman.. We are losing hope in justice 

Hari
 - 
Friday, 11 Aug 2017

These investigation is nothing but for making loop hole and helping the crimnals to escape

Sukesh
 - 
Friday, 11 Aug 2017

Simply wasting time for useless matters.. All evidences against that cruel lady and her son. Still police want more..?

Rakesh
 - 
Friday, 11 Aug 2017

Why wasting money for these murderers... they agreed they killed. then why this drama.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Media Release
February 10,2020

Mangaluru, Feb 10: Sandeep Malani has been of lately winning back to back awards at various events and film festivals. Being an actor, he has won 3 Best Actor awards (2 for his gripping performance in the Kannada feature film, Mookavismitha, directed by Gurudutt Sreekanth and one award for his multi faceted performance in the short film, Nishyabda Nishi directed by his son Silver). These awards were honored at the Indian Cine Film Festival in Mumbai and Karunadu Kannada Rathna Award in Bengaluru.

He also won an award for his woman empowerment film, Sulige Sikkidaaga in Pune, while his musical documentary on Sridevi titled SrideviBaaz won him two awards at Pune and Kolhapur International film festivals. His other short film on transgender Mamta (Maternal Love) won the Audience Awards in USA.

Very recently he was honored by the Filmaholic Foundation in Bengaluru for being a successful short film maker with two Kannada films Jo Jo Laali and Sulige Sikkidaaga, both featuring award winning actress Kalpana Pandit, winning multiple awards and making news at International Film Festivals. This honor was given at the Karnataka Youth International Short Film Festival.

With donning so many feathers of awards in his hat, he recently bagged the most prestigious one; that being receiving the Award for Best Feature Film shot on Mobile for his film ‘Maa – Yeh CineMaa Hai’ shot on iPhone at the 1st ever IMFF India (International Mobile Film Festival India 2020) held at World Trade Center, Mumbai on 8th February.

With a whole lot short films in the category and barely few feature films in the Feature Film Category, Malani verged out to be the winner as his Hindi film was a complete family entertainer that of 5 songs, sentiment value, and a wholesome entertainer with 100 artists working in the film that consists of stage and television actors, newcomers, models and common people. The film starred Sandeep’s family members playing important roles. His mother, Meena Malani (playing the title role), wife Reshma Malani (playing one of the lead actress) and son Silver Malani (playing an important character). The cast includes Mahesh Dulam, Anita Dulam, Ranjeet Jha, Bharath Lakshmikanth, Mahendra Pandey, Vishal Digani, Akash Hora, Shuba Raksha, Sanjukta Ghosh, Sharanya Kaur, Varsha Acharya, Kkewal Sharma, Anant Joshi, Vivek Punjabi, Valerian Menezes, Nigel Pereira. Veteran actresses Sarojini Shetty, Deepali Khambadkone, Vinny Fernandes also features in the film while Kalpana Pandit, Sudha Chandran, Sonal Monteiro, Adaa Khan and others give a social message on mother, womanhood and empowerment.  The film has been jointly produced by RKJ Film Productions, The Studio Agency and Malani Talkies.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 24,2020

Bengaluru, Jun 24: Three weeks after the BMTC resumed running air-conditioned buses in the state capital, the state-owned Karnataka State Road Transport Corporation (KSRTC) has announced plying AC buses to eight cities to begin with, including to Mangaluru and Mysuru, from Thursday.

From tomorrow travellers can travel to Mysuru, Mangaluru, Kundapura, Madikeri, Chikkamagaluru, Davanagere, Shivamogga and Virajpet in AC buses, KSRTC said in a statement released here.

Listing out the measures taken to check the spread of Covid-19, the Corporation said that the temperature inside the buses will be maintained at 24 to 25 degrees Celsius and no blankets will be provided in the night service buses.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.